Company Zhejiang Yatai Pharmaceutical Co., Ltd.

Company Zhejiang Yatai Pharmaceutical Co., Ltd.

002370

CNE100000MM5

Pharmaceuticals

Equities

002370

CNE100000MM5

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
3.35 ^CNY	-2.33%		+2.13%	-21.91%

26/04	Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/03	Zhejiang Yatai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zhejiang Yatai Pharmaceutical Co., Ltd. is a China-based company engaged in the manufacture and distribution of drugs. The Company's main business consists of the research, development, production and sales of chemical agents, chemical raw materials and diagnostic reagents, as well as the provision of pharmaceutical research and development outsourcing (CRO) services. The Companyâs chemical agents are classified as antibiotics and non-antibiotic drugs. Along with its subsidiaries, the Company provides preclinical research services, clinical research services and other advisory services. The Company distributes its products primarily in domestic markets and overseas markets.

Number of employees: 528

CNY in Million	2022	Weight	2023	Weight	Delta
Antibiotics Preparations 67.8 %	244	65.5 %	285	67.8 %	+16.72%
Other Services 24.2 %	87	23.4 %	102	24.2 %	+16.59%
Digestive System 7.1 %	41	11.0 %	30	7.1 %	-27.48%
Other Business 0.9 %	1	0.2 %	4	0.9 %	+537.57%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	373	100.0 %	421	100.0 %	+12.64%

Managers	Title	Age	Since
Xiao Ming Huang CEO	Chief Executive Officer	61	15/22/15
Jing Yang Xu DFI	Director of Finance/CFO	43	15/22/15
Wei Huang BRD	Director/Board Member	44	15/22/15
Wei Xu SEC	Corporate Secretary	40	15/22/15
Bao Kun Hu PRN	Corporate Officer/Principal	54	23/07/23

Members of the board	Title	Age	Since
Hua Ying Zhou BRD	Director/Board Member	55	15/22/15
Ling Jie Song CHM	Chairman	35	15/22/15
Cai Fu BRD	Director/Board Member	56	04/22/04
Xiao Ming Huang CEO	Chief Executive Officer	61	15/22/15
Ya Jian Zhou BRD	Director/Board Member	37	15/22/15
Wei Huang BRD	Director/Board Member	44	15/22/15
Yue Hui Liu BRD	Director/Board Member	49	15/22/15
Min Cai BRD	Director/Board Member	38	12/22/12
Yi Feng Cai CHM	Chairman	55	15/22/15
Hai Zhou Lu BRD	Director/Board Member	49	07/22/07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	609,179,371	441,258,652 ( 72.43 %)	0	72.43 %

Name	Equities	%	Valuation
Zhong Ou Asset Management Co., Ltd 0.4812 %	2,231,100	0.4812 %	1 M ¥
China Southern Asset Management Co., Ltd. 0.0439 %	203,400	0.0439 %	99 625 ¥
Sealand Securities Co., Ltd. (Investment Management) 0.0351 %	162,600	0.0351 %	79 641 ¥

Zhejiang Yatai Pharmaceutical Co., Ltd.

36 Nanbin West Road Lihai Town

312366, Shaoxing

http://www.ytyaoye.com

address Zhejiang Yatai Pharmaceutical Co., Ltd.(002370)

Company calendar

	1st Jan change	Capi.
ZHEJIANG YATAI PHARMACEUTICAL CO., LTD.	-21.91%	282M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals